biostudies-literatureUnknown104(4)Halpern ABNHLBI NIH HHSNCI NIH HHSHaematologicae143-e146https://www.ebi.ac.uk/biostudies/studies/S-EPMC6442971biostudies-literaturePhase I/II trial of cladribine, high-dose cytarabine, mitoxantrone, and G-CSF with dose-escalated mitoxantrone for relapsed/refractory acute myeloid leukemia and other high-grade myeloid neoplasms.PMC6442971T32 HL007093T32 CA009515Othus MOrlowski KFOehler VGScott BLGardner KMOrozco JJHendrie PCChen TLPercival MMBecker PSHuebner EMAnwar ACassaday RDWalter RBHalpern ABSmith HABuckley SAEstey EHfalsePhase I/II trial of cladribine, high-dose cytarabine, mitoxantrone, and G-CSF with dose-escalated mitoxantrone for relapsed/refractory acute myeloid leukemia and other high-grade myeloid neoplasms.2019-01-01T00:00:00Z2019 Apr2026-05-03T19:03:20.645Z2025-04-06T15:45:17.279ZS-EPMC64429713040979810.3324/haematol.2018.204792